Non-invasive Brain Stimulation Using Tdcs of the Third (of Many) Visual Pathways
Sensory Contributions to Third Visual Pathway Dysfunction in Schizophrenia: Correlation and Causation
Get research updatesSchizophrenia can affect how a person perceives reality, thinks and feels, sometimes involving hearing voices or holding unusual beliefs.
Sensory Contributions to Third Visual Pathway Dysfunction in Schizophrenia: Correlation and Causation
Patientheque in Patients With a Psychosis
Read the official source — NCT05340348Formation of a Patientheque in Patients With a Beginner Psychosis
Study of Life Challenges, Personality, and Emotional Experiences
RCT Comparing Avatar Intervention to Supportive Intervention to Reduce Cannabis Use in Patients With Psychotic Disorders
Read the official source — NCT05704582A Randomized Controlled Trial Comparing Avatar Intervention to an Addiction Supportive Intervention to Reduce Cannabis Use in Patients With Psychotic Disorders
Pilot Study of the Cognitive and Neurobiological Effects of the Clubhouse Model of Psychosocial Rehabilitation for Schizophrenia and Related Conditions
A Phase 3 Double-blind, Placebo-controlled Randomized Withdrawal Maintenance Trial of KarXT Treatment in Participants With Schizophrenia
Skills Group for Youth at Clinical High-Risk for Psychosis
Read the official source — NCT05398120Testing the Feasibility of a Skills Group for Adolescents and Young Adults at Clinical High-risk for Psychosis
Researchers are studying Ublituximab to find out how it affects psychotic symptoms in people with schizophrenia.
Supporting Patients by Family Education in Psychotic Illness: A Prospective Cohort Study
Read the official source — NCT05500001Supporting Patients by Family Education in Psychotic Illness: A Prospective Cohort Study
Effectiveness of a Tele-group Cognitive Behavioural Family Intervention (tgCBFI) for People With Schizophrenia and Their Families: a Mixed-method Study
Understanding of Psychotic Disorders in Children With 22q11.2DS
Read the official source — NCT04639388Characterize the Behavioral Prodromes of Psychotic Disorders in Children With 22q11.2DS Aged From 4 to 13 Years Old
Automatic Measurement of Antipsychotic Medication Adherence in Schizophrenia Through Speech (OBSERVSPEECH)
We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.